Recent advances in asthma.
作者信息
Barnes P J, Lee T H
机构信息
Department of Thoracic Medicine, National Heart and Lung Institute, London, UK.
出版信息
Postgrad Med J. 1992 Dec;68(806):942-53. doi: 10.1136/pgmj.68.806.942.
Abstract
摘要
相似文献
1
Recent advances in asthma.哮喘的最新进展
Postgrad Med J. 1992 Dec;68(806):942-53. doi: 10.1136/pgmj.68.806.942.
2
Recent advances in the treatment of asthma.哮喘治疗的最新进展。
Curr Opin Pulm Med. 1996 Jan;2(1):1-6.
3
Long-acting beta 2-agonists: the new symptom controllers for asthma.
Med J Aust. 1999 Sep 6;171(5):255-8.
4
Long acting beta2 agonists: are they safe?长效β2激动剂：它们安全吗？
Ceylon Med J. 2006 Dec;51(4):129-31. doi: 10.4038/cmj.v51i4.1140.
5
The FDA and safe use of long-acting beta-agonists in the treatment of asthma.美国食品药品监督管理局与长效β受体激动剂在哮喘治疗中的安全使用。
N Engl J Med. 2010 Apr 1;362(13):1169-71. doi: 10.1056/NEJMp1002074. Epub 2010 Feb 24.
6
Changes in recommended treatments for mild and moderate asthma.轻度和中度哮喘推荐治疗方法的变化。
J Fam Pract. 2004 Sep;53(9):692-700.
7
[Treatment of moderate persistent asthma: inhalation corticosteroids in combination with long acting beta 2-adrenergic agonists (bronchodilators) then with leukotriene receptor antagonists (anti-inflammatory agents); the 'step-3-dilemma'].中度持续性哮喘的治疗：吸入性糖皮质激素联合长效β2肾上腺素能激动剂（支气管扩张剂），然后联合白三烯受体拮抗剂（抗炎药）；“第三步困境”
Ned Tijdschr Geneeskd. 2003 Aug 30;147(35):1681-5.
8
Assessing the safety of adding LABAs to inhaled corticosteroids for treating asthma.评估在吸入性糖皮质激素中添加长效β2受体激动剂治疗哮喘的安全性。
N Engl J Med. 2011 Jun 30;364(26):2473-5. doi: 10.1056/NEJMp1104375.
9
Drugs for ambulatory asthma.用于非住院哮喘的药物。
Med Lett Drugs Ther. 1993 Feb 5;35(889):11-4.
10
[New viewpoints on therapy with beta-2-agonist-type bronchodilators and corticosteroids in bronchial asthma].[关于支气管哮喘中β-2激动剂类支气管扩张剂和皮质类固醇治疗的新观点]
Pneumoftiziologia. 1992 Oct-Dec;41(4):257-8.
引用本文的文献
1
Age by Single Nucleotide Polymorphism Interactions on Bronchodilator Response in Asthmatics.年龄与单核苷酸多态性相互作用对哮喘患者支气管扩张剂反应的影响
J Pers Med. 2021 Jan 19;11(1):59. doi: 10.3390/jpm11010059.
2
Treatment of childhood asthma. Options and rationale for inhaled therapy.儿童哮喘的治疗。吸入疗法的选择及理论依据。
Drugs. 1998 Feb;55(2):237-52. doi: 10.2165/00003495-199855020-00005.
3
Association between genetic polymorphisms of the beta2-adrenoceptor and response to albuterol in children with and without a history of wheezing.有喘息病史和无喘息病史儿童的β2肾上腺素能受体基因多态性与沙丁胺醇反应之间的关联
J Clin Invest. 1997 Dec 15;100(12):3184-8. doi: 10.1172/JCI119874.
4
Air pollution and asthma.空气污染与哮喘。
Postgrad Med J. 1994 May;70(823):319-25. doi: 10.1136/pgmj.70.823.319.
5
Inhaled fluticasone propionate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in asthma.吸入用丙酸氟替卡松。其药效学和药代动力学特性以及在哮喘治疗中的应用综述。
Drugs. 1994 Feb;47(2):318-31. doi: 10.2165/00003495-199447020-00007.
本文引用的文献
1
The effect of inhaled vasoactive intestinal peptide on bronchial reactivity to histamine in humans.吸入血管活性肠肽对人体支气管组胺反应性的影响。
Am Rev Respir Dis. 1984 Aug;130(2):162-6. doi: 10.1164/arrd.1984.130.2.162.
2
The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients.
J Allergy Clin Immunol. 1988 Sep;82(3 Pt 1):470-80. doi: 10.1016/0091-6749(88)90021-8.
3
Presence of tumour necrosis factor or a related factor in human basophil/mast cells.人类嗜碱性粒细胞/肥大细胞中肿瘤坏死因子或相关因子的存在。
Immunology. 1989 Mar;66(3):445-50.
4
The role of thromboxane A2 in the pathogenesis of airway hyperresponsiveness.血栓素A2在气道高反应性发病机制中的作用。
Eur Respir J. 1989 Sep;2(8):782-6.
5
Gene regulation by steroid hormones.类固醇激素对基因的调控。
Cell. 1989 Feb 10;56(3):335-44. doi: 10.1016/0092-8674(89)90237-7.
6
Identification and characterization of a monocyte-derived neutrophil-activating factor in corticosteroid-resistant bronchial asthma.皮质类固醇抵抗型支气管哮喘中单核细胞衍生的中性粒细胞激活因子的鉴定与表征
J Clin Invest. 1989 Dec;84(6):1930-41. doi: 10.1172/JCI114381.
7
Identification of an alveolar macrophage-derived activity in bronchial asthma that enhances leukotriene C4 generation by human eosinophils stimulated by ionophore A23187 as a granulocyte-macrophage colony-stimulating factor.鉴定支气管哮喘中一种由肺泡巨噬细胞产生的活性，该活性作为粒细胞-巨噬细胞集落刺激因子，可增强离子载体A23187刺激的人嗜酸性粒细胞中白三烯C4的生成。
Am Rev Respir Dis. 1989 Nov;140(5):1340-7. doi: 10.1164/ajrccm/140.5.1340.
8
Prevalence of asthma in Finnish young men.芬兰年轻男性中哮喘的患病率。
BMJ. 1990 Aug 4;301(6746):266-8. doi: 10.1136/bmj.301.6746.266.
9
Exposure to house-dust mite allergen (Der p I) and the development of asthma in childhood. A prospective study.接触屋尘螨过敏原（Der p I）与儿童哮喘的发病。一项前瞻性研究。
N Engl J Med. 1990 Aug 23;323(8):502-7. doi: 10.1056/NEJM199008233230802.
10
Mast cells as a source of both preformed and immunologically inducible TNF-alpha/cachectin.肥大细胞作为预先形成的和免疫诱导性肿瘤坏死因子-α/恶病质素的来源。
Nature. 1990 Jul 19;346(6281):274-6. doi: 10.1038/346274a0.
Zotero 插件